BackMirum Pharmaceuticals Overview

Mirum Pharmaceuticals Operating Income

Operating Income for MIRM.

Quarterly Operating Income

$-789465000.00
5099.66% YoY

As of Mar 31, 2026

Annual Operating Income (TTM)

$-796418000.00
943.51% YoY

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)